US2016251345A1PendingUtilityA1

Amorphous Salt of a Macrocyclic Inhibitor of HCV

49
Assignee: JANSSEN PHARMACEUTICALS INCPriority: Feb 27, 2009Filed: Mar 8, 2016Published: Sep 1, 2016
Est. expiryFeb 27, 2029(~2.6 yrs left)· nominal 20-yr term from priority
Inventors:Peter Jozef Maria Van RemoortereRoger Petrus Gerebern VandecruysHerman Augustinus De Kock
C07D 417/04A61P 31/14C07D 417/14C07D 403/12A61K 31/4725A61K 31/4709A61P 31/00A61K 9/14A61P 43/00
49
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The amorphous form of the sodium salt of the macrocyclic inhibitor of HCV of formula: as well as processes for manufacturing this salt.

Claims

exact text as granted — not AI-modified
1 . The sodium salt of the compound of formula I: 
       
         
           
           
               
               
           
         
       
       in solid amorphous form. 
     
     
         2 - 7 . (canceled) 
     
     
         8 . A pharmaceutical composition comprising the sodium salt of the compound  claim 1 , and a pharmaceutically acceptable carrier. 
     
     
         9 - 10 . (canceled)

Join the waitlist — get patent alerts

Track US2016251345A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.